Results of MDMA-PTSD study presented at conference by Mithoefer and colleagues

entactogen, human 3 Comments

Nature has a news story by Arran Frood (who seems to cover the psychedelic news beat) that discusses the recently completed first U.S. study of MDMA in combination with psychotherapy as a treatment for posttraumatic stress disorder (PTSD).

Results of the study, carried out by Michael Mithoefer and colleagues in South Carolina and sponsored by the Multidisciplinary Association for Psychedelic Studies, were just presented in poster form at the annual meeting of the International Society for Traumatic Stress Studies. The abstract is reproduced at the bottom of this entry.

(Because conference presentations are not peer-reviewed and often present preliminary analyses, scientists often reserve judgment until the formal paper is published in a peer-reviewed journal and they can read the details for themselves. However, the preliminary results sound promising.)

According to the Nature news piece:
Read the rest…

MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder

entactogen, human 1 Comment

José Carlos Bouso and colleagues have published a paper in the Journal of Psychoactive Drugs on his aborted study of MDMA as an adjunct to psychotherapy for treatment of Posttraumatic Stress Disorder in women.
Read the rest…

New MDMA and Psilocybin research results presented at CPDD conference

entactogen, hallucinogen, human, in vivo 5 Comments

Looking back on the College on Drug Dependence annual meeting, a number of standout presentations about MDMA and psychedelics (or ‘hallucinogens’ as we scientists call them) spring to mind. Here, I highlight just three of them even though I could spend hours and pages discussing a larger number of fascinating presentations.
Read the rest…